Time flies with great content! Renew in to keep enjoying all our premium content.
Prime
Insulin demand up as diabetes among children gains attention
Kenya relies on imported insulin from major pharmaceutical companies such as Novo Nordisk (Denmark), Sanofi (France) and Eli Lilly (USA), making it vulnerable to global price fluctuations and foreign currency shocks.
Pharmacies in Kenya are reporting an increase in demand for insulin as more children across the country are being diagnosed with Type 1 diabetes, which requires lifelong treatment.
At Kenyatta National Hospital (KNH), for instance, over 500 children are currently undergoing follow-up care, each of them requiring daily insulin injections to survive.
